FDA issued a Warning Letter to Sal Pharma on 4/20/2017 as a result of this inspection.
483 Sal Pharma Jul 2016

483 Sal Pharma Jul 2016

Doan Nguyen FDA$119.00 - Available Now

FDA investigators audited the Sal Pharma - Hyderabad, India facility and issued inspectional observations (via FDA 483) on 01 Jul 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Jul 2016
  • Location: Hyderabad, India
  • FEI: 3003916387
Add To Cart